{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.4","upperLimit":"4.1","value":"2.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"description":"Patients receive therapeutic angiotensin-(1-7) SC once daily in the absence of disease progression or unacceptable toxicity.","id":"OG000","title":"Treatment (Antiangiogenesis Therapy)"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Approximately 5 years","title":"Time to Disease Progression","type":"SECONDARY","unitOfMeasure":"months"}